Antibody responses following the surge of SARS-CoV-2 Omicron infection among patients with systemic autoimmune rheumatic diseases
Nan Xiang(Xi’an Jiaotong-Liverpool University), Chen Zhu(Hunan University of Science and Technology), Dali Tong(University of Science and Technology of China), Yuwei Li(Sun Yat-sen University), Qian Wang(Hebei Medical University), Yujing Li(University of Science and Technology of China), Yaxin Zhang(University of Science and Technology of China), Xue Tian(University of Science and Technology of China), Mengyao Liu(University of Science and Technology of China), Qi-Qin Wu(University of Science and Technology of China), Hui-Zhi Jin(University of Science and Technology of China), Tengchuan Jin(Anhui Medical University), Wei Bao(Qingdao University)
Cited by 2
Related Papers
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease
|Neuron|2018|525
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
|Proceedings of the National Academy of Sciences|2013|342
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
|Frontiers in Chemistry|2021|311
Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy <i>via</i> Immune Activation and Checkpoint Inhibition
|ACS Nano|2020|271
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction
|Nature Communications|2015|202